Offer - Urjas Oil for just ₹ 1 X
Polaramine 6 Tablet is a prescription medicine that is available as a Tablet. Allergic Rhinitis are some of its major therapeutic uses. The alternative uses of Polaramine 6 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Polaramine 6 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Polaramine 6 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Polaramine 6 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Polaramine 6 Tablet's effect during pregnancy is Safe and Unknown while nursing. It is important to know if Polaramine 6 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Polaramine 6 Tablet related warnings section.
Individuals suffering from medical conditions like Glaucoma must refrain from the use of Polaramine 6 Tablet since this can cause severe adverse effects. Other contraindications of Polaramine 6 Tablet have been discussed in the sections ahead.
Drug reaction of Polaramine 6 Tablet with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Polaramine 6 Tablet is considered not safe while driving, and is not addictive.
Polaramine 6 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Polaramine 6 Tablet safe for pregnant women?
Polaramine is safe to take during pregnancy.
Is the use of Polaramine 6 Tablet safe during breastfeeding?
Information about safety of Polaramine for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Polaramine 6 Tablet on the Kidneys?
Polaramine may have mild side effects on the kidneys.
What is the effect of Polaramine 6 Tablet on the Liver?
Polaramine has very mild side effects on the liver.
What is the effect of Polaramine 6 Tablet on the Heart?
Polaramine may have mild side effects on the heart. Most people will never see any effect on the heart.
Polaramine 6 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Polaramine 6 Tablet unless your doctor advises you to do so -
Is this Polaramine 6 Tablet habit forming or addictive?
Forming a habit of Polaramine 6 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Polaramine 6 Tablet, you should not drive or work on any heavy machine, as Polaramine 6 Tablet can make you drowsy.
Is it safe?
Yes, but take Polaramine 6 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Polaramine 6 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Polaramine 6 Tablet
There is no information on the effects of taking Polaramine 6 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Polaramine 6 Tablet
Consuming Polaramine 6 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,165